GSK and Drug Industry Push for E-Cigarette Regs

Feb 20, 2014

Bloomberg

GlaxoSmithKline Plc is lobbying for more stringent regulation of electronic cigarettes, which compete with its Nicorette gum and other smoking cessation products.

According to Bloomberg, GSK is urging the European Commission to require e-cigarettes to be licensed as medicines. The commission is revising the Tobacco Products Directive to regulate products such as e-cigarettes that don’t contain tobacco, yet are linked to tobacco use.

Glaxo, Johnson & Johnson and Novartis AG all make smoking cessation products that compete with e-cigarettes.

Read the Bloomberg press release

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments